Effectiveness of ayurvedic formulation, NAOQ19 along with standard care in the treatment of mild-moderate COVID-19 patients: A double blind, randomized, placebo-controlled, multicentric trial

Medicines in indigenous systems such as Ayurveda have strong antimicrobial activity but double-blind randomized control trials are infrequent in this system of medicine. The efficacy of a new ayurvedic formulation was evaluated during the pandemic. 150 mild-moderate COVID-19 patients were enrolled a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of ayurveda and integrative medicine 2023-11, Vol.14 (6), p.100778, Article 100778
Main Authors: Bhardwaj, Pankaj, Ganapathy, Kalaiselvan, Pathania, Monika, Naveen, K.H., Charan, Jaykaran, Dutta, Siddhartha, Gadepalli, Ravisekhar, Srinivasan, Srikanth, Gupta, Manoj Kumar, Goel, Akhil D., Midha, Naresh, Kumar, Bharat, Sharma, Meenakshi, Sharma, Praveen, Banerjee, Mithu, Mitra, Prasenjit, Misra, Sanjeev, V, Vinayagamoorthy, Subramaniant, Girija, R, Praveen, Dhar, Minakshi, Saxena, Vartika, Dhamija, Puneet, Singh, Archana, Subramanian, Saumya, Kanchibhotla, Divya
Format: Article
Language:English
Subjects:
antimicrobial properties
Antiviral drugs
Ayurveda
Ayurvedic medicine
Clinical trials
Coronavirus
COVID-19 infection
Covid-19 pandemic
COVID-19 vaccines
Flu like symptoms
Herbs
hospitals
Infections
Integrative medicine
Original
pandemic
Pandemics
Patients
people
Phytochemicals
placebos
Proteins
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Standard of care
therapeutics
Viral illness
viruses
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!